SBRI Healthcare Awards INR 32 Crore to Healthtech Startup Qure.ai in Late-Stage Healthcare Innovations Competition
The SBRI Healthcare, which is part of the UK government's National Health Service (NHS), has awarded £3.2 million (over INR 32 crore) to Mumbai-based healthtech firm Qure.ai in a competition for late-stage healthcare innovations.
The SBRI grant was made possible by a collaboration between the NHS Cancer Programme and the Accelerated Access Collaborative. The assisted chest X-ray triage system developed by Qure.ai improves diagnostic efficiency and lung cancer detection.
The SBRI competition began in March 2021, and a second edition is scheduled for spring 2022. Qure.ai was one of eight startups to receive more than GBP 9 million in funding for projects that aim to improve cancer detection and diagnosis.
To detect brain trauma and diagnose chest diseases, Qure employs AI algorithms. The healthtech startup, founded in 2016 by Prashant Warier and Dr. Pooja Rao, uses AI and deep learning technology to analyse radiology images for a quick and accurate diagnosis, reducing treatment time. It most recently raised $16 million in a funding round led by Sequoia India and MassMutual Ventures to expand its product line and expand into new geographies.
Fractal Analytics incubated the company and invested $30 million in the early stages. Warier, a cofounder of Qure.ai, previously founded Imagna Analytics, an AI-powered personalised digital marketing firm that was acquired by Fractal Analytics in 2015.
Qure.ai's cancer detection solution is available in 50 countries and over 500 locations, with 4 million patients served to date. Qure.ai's business model entails selling diagnostic tools directly to hospitals, as well as collaborating with health-focused non-profits and medical device companies.
According to the company, its algorithm can detect clinically relevant abnormal trauma from X-rays, CT scans, and MRIs in a fraction of the time it takes doctors. The chest X-ray tools have also been deployed at a few primary health care (PHC) centres in Indian villages to speed up tuberculosis screenings. They can even detect 29 clinically relevant lung abnormalities, including Covid-19 indications.
The company worked with NITI Aayog, the Piramal Foundation's Piramal Swasthya initiative, and the PATH NGO in India. Qure.ai's chest X-rays solution has been implemented in Uttar Pradesh and Rajasthan, with over 10,000 patients served. The Maharashtra government used the company's qXR solution for mass screenings of suspected Covid-19 patients in 2020.
The SBRI grant was made possible by a collaboration between the NHS Cancer Programme and the Accelerated Access Collaborative. The assisted chest X-ray triage system developed by Qure.ai improves diagnostic efficiency and lung cancer detection.
The SBRI competition began in March 2021, and a second edition is scheduled for spring 2022. Qure.ai was one of eight startups to receive more than GBP 9 million in funding for projects that aim to improve cancer detection and diagnosis.
To detect brain trauma and diagnose chest diseases, Qure employs AI algorithms. The healthtech startup, founded in 2016 by Prashant Warier and Dr. Pooja Rao, uses AI and deep learning technology to analyse radiology images for a quick and accurate diagnosis, reducing treatment time. It most recently raised $16 million in a funding round led by Sequoia India and MassMutual Ventures to expand its product line and expand into new geographies.
Fractal Analytics incubated the company and invested $30 million in the early stages. Warier, a cofounder of Qure.ai, previously founded Imagna Analytics, an AI-powered personalised digital marketing firm that was acquired by Fractal Analytics in 2015.
Qure.ai's cancer detection solution is available in 50 countries and over 500 locations, with 4 million patients served to date. Qure.ai's business model entails selling diagnostic tools directly to hospitals, as well as collaborating with health-focused non-profits and medical device companies.
According to the company, its algorithm can detect clinically relevant abnormal trauma from X-rays, CT scans, and MRIs in a fraction of the time it takes doctors. The chest X-ray tools have also been deployed at a few primary health care (PHC) centres in Indian villages to speed up tuberculosis screenings. They can even detect 29 clinically relevant lung abnormalities, including Covid-19 indications.
The company worked with NITI Aayog, the Piramal Foundation's Piramal Swasthya initiative, and the PATH NGO in India. Qure.ai's chest X-rays solution has been implemented in Uttar Pradesh and Rajasthan, with over 10,000 patients served. The Maharashtra government used the company's qXR solution for mass screenings of suspected Covid-19 patients in 2020.
.jpg "Radiance Renewables: Driving Sustainable Inno-vation in India's Renewable Energy Landscape")
